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Abstract 
THE ROLE OF GONADAL HORMONES ON OPIOID RECEPTOR PROTEIN 
DENSITY IN ARTHRITIC RATS 
Matthew Christopher Kren, M.S. 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science at Virginia Commonwealth University. 
Virginia Commonwealth University, 2006 
Directory: Dr. Sandra Welch 
Associate Professor, Department of Pharmacology and Toxicology 
The majority of research on the endogenous opioid system has focused on various 
pain assays and the efficacy of different opioid agonists. However, minimal attention has 
been focused on the effects of gonadal hormones and their impact on the opioid peptide 
system. The present study was designed to determine the effects of modulation of 
gonadal hormones on the opioid receptor protein levels in Complete Freund's Adjuvant 
(CFA)-treated arthritic and non-arthritic male and female Lewis rats. Midbrain and 
spinal cord tissues were collected for comparison of the p, 6, and K receptor protein 
levels in arthritic and non-arthritic animals. Male gonadectomy did not dramatically 
impact opioid receptor protein levels, whereas female gonadectomy resulted in 
significant increases in opioid receptor protein levels. Furthermore, it was determined 
that MOR protein levels were greatest in male rats, while KOR protein levels were 
greatest in female rats regardless of arthritis condition or gonadal hormones. 
Introduction 
History of Opioids 
Opium, a substance derived from the poppy plant, Papaver somniferum, has been 
used throughout history and in almost every culture to alleviate pain and other ailments. 
Although much of the early history of opium is unclear, it appears that cultures that used 
the juices from the unripe seed of the poppy plant understood its power. Historical 
references indicate that the Sumerians were the first civilization to use opium, possibly 
first used by priests as a euphoriant in religious ceremonies (Aragon-Poce et al., 2002). 
Opium's euphoria and analgesic properties undoubtedly led to its popularity over many 
of the herbal drugs used prior to opium. By the thirteen century A.D. opium use had 
spread from the Middle East, to Greece, Rome, Asia, and throughout Europe. 
Afier opium had been used for centuries to treat ailments such as headaches, 
surgical pain, and to produce constipation, its active ingredient was isolated in 1806. 
German scientist, Friedrich Serturner, discovered the specific alkaloid in opium 
responsible for its profound effects and named it morphine, after the Greek god of 
dreams, Morpheus (Brownstein, 1993). Scientists continukd to explore the alkaloids 
found in the juices of Papaver somniferum and discovered substances like codeine, 
thebaine, and papaverine; however the greatest advances in understanding the effects of 
opiates occurred after scientists began to understand and modify the chemical structure of 
these alkaloids. 
Unfortunately, the analgesic benefits of treatment with opium, morphine, and 
codeine were plagued by their ability to produce tolerance and addiction. Heroin was the 
first attempt at producing a drug that was able to alleviate pain like morphine, but without 
causing addiction. However, after Bayer released heroin in 1898, its claims of providing 
non-addictive pain relief were proven false (Corbett et al., 2006). This search to 
synthetically produce substances with similar or greater analgesic effects not only led to 
the discovery of numerous other opioid drugs, like methadone, oxycodone, and fentanyl, 
but also provided a view into the mechanisms that produced the desired analgesia. The 
synthetic opioid nalorphine provided the initial insight into the mechanism of opioid 
analgesia. Scientists discovered that nalorphine was able to produce analgesia, while 
antagonizing the analgesic effects of morphine. The mixed effect of nalorphine was the 
action of a mixed agonist-antagonist, which indicated the presence of multiple receptors 
within the opioid system (Brownstein, 1993). 
Opioid Receptors 
As more opioid agonists, antagonists, and mixed agonist-antagonists were 
developed and studied the theory of multiple opioid receptors was reaffirmed. The initial 
evidence for multiple receptors came from Gilbert and Martin (1 976) where they tested 
morphine- and nalorphine-like drugs on chronic spinal dogs. Ultimately, it was 
determined that there were three opioid receptors working at the same time and named 
them according to their agonists, y for morphine, K for ketazocine, and a for N- 
allylnormetazocine (SKF 10047) (Martin et al., 1976). This discovery was followed by 
the subsequent proposal of the 6 receptor in order to explain the activity of enkephalin, a 
peptide known at the time to interact with opioid receptors (Lord, 1977). 
The overall understanding of the opioid receptors was greatly advanced when the 
receptor were successfully cloned in the 1990's. In 1992, the 6 receptor (DOR) was first 
to be cloned. (Evans et al., 1992; Kieffer et al., 1992). Then, in 1993, the y receptor 
(MOR) (Chen et al., 1993a,b; Fukuda et al., 1993; Thompson et al., 1993) and K receptor 
(KOR) (Li et al., 1993; Meng et al., 1993; Minami et al., 1993; Nishi et al., 1993). 
However, the a receptor, originally discovered by Martin et al. is no longer considered an 
opioid receptor since it lacks the stereoselectivity and antagonism by opioid antagonists 
that is characteristic of opioid receptors (Corbett et al., 2006). Then an orphan opioid 
receptor, with almost 70% sequence homology to the other opioid receptors, was 
identified in 1997 (Henderson and McKnight, 1997). After the discovery of the 'orphan' 
receptor, called opioid receptor-like receptor (ORLl), the list of accepted opioid 
receptors remains: y, 6, K, and ORLI. 
Endogenous Opioid Peptides 
Discovering the presence of multiple opioid receptors was pivotal in the 
advancement of understanding of the opioid receptor system. Unfortunately, this did not 
explain why the juices of the poppy plant had such a profound interaction with the opioid 
receptors and were able to produce its popular analgesic effect. These interactions were 
explained by the discovery of the endogenous opioid peptides, including the dynorphins, 
enkephalins, and endorphins. In 1975, Hughes et al. observed that a substance from 
guinea pig brain acted as an agonist at opioid receptors, but its effect was antagonized by 
naloxone. This substance was later determined to contain a mixture of the first two 
endogenous opioid peptides, methionine-enkephalin and leucine-enkephalin (shortened to 
[Met5]- and [Leu5]-enkephalins) (Hughes et al., 1975). Following the discovery of the 
enkephalins, opiate-like activity was observed in peptides found in pituitary glands, 
which led to another class of endogenous opioid peptides, the dynorphins (Goldstein et 
al., 1975). The last class of endogenous opioid peptides, the endorphins, was discovered 
with P-endorphin isolated from human and camel pituitary glands (Li and Chung, 1976). 
The endogenous opioid peptides are derived from larger peptides found within the 
body. Proenkephalin (PENK), Prodynorphin (PDYN), and Pro-opiomelanocortin 
(POMC) function as precursor peptides for enkephalins, dynorphins, and B-endorphin, 
respectively (Przewlocki R. and Przewlocki B., 2001). Proenkephalin is the source of 
[Met5]- and [Leu5]-enkephalins and several longer peptides, including Peptide E, BAM 
22P, and Metorphamide (Corbett et al., 2006). PENK-containing neurons are expressed 
in neuronal and nonneuronal sites throughout the central and peripheral nervous system 
(Przewlocki R. and Przewlocki B., 2001). [ ~ e t ~ ] -  and [Leu5]-enkephalins derived from 
PENK have high affinities for DOR. Prodynorphin (PDYN) functions as a precursor 
peptide for the dynorphins, alpha and beta neoendorphin, and as the primary source of 
[Leu5]-enkephalin. PDYN-containing neurons are localized in areas of the brain and 
peripheral nervous system associated with nociception (Watson et al., 198 1). Opioid 
fragments of PDYN have the greatest affinity for KOR, but also display significant 
affinity at MOR and DOR (Corbett et al., 1993). 
The peptide pro-opiomelanocortin (POMC) is the source of P-endorphins (1-27) 
and several non-opioid peptides. POMC is also the precursor to adrenocorticotropin 
hormone (ACTH), melanocyte-stimulating hormone (MSH), and P -1ipotropin. P - 
endorphin peptides bind with similar affinity to MOR and DOR and with a lower affinity 
to KOR. P -endorphin peptides are present in the nucleus arcuatus of the mediobasal 
hypothalamus and function in pain response (Przewlocki R. and Przewlocki B., 2001). 
G Protein Superfamily 
MOR, DOR, KOR, and ORL-1 opioid receptors are members of the G protein 
coupled receptor superfamily. G proteins are heterotrimers composed of a ,  P, and y 
subunits bound to either a guanosine diphosphate (GDP) or guanosine triphosphate 
binding protein (GTP) (Shaqura et al., 2004). Opioid receptors are coupled to G protein 
heterotrimers, which become activated through the binding of a opioid ligand to the 
receptor (Forse, 2000). Once activated the G protein changes conformation, resulting in a 
decreased affinity for the GDP binding protein (Neer, 1995). After releasing GDP, the a 
subunit is activated by binding a GTP, causing the a subunit to dissociate from the Py 
subunit. Eventually, the GTP is hydrolyzed from the a subunit by the enzyme GTPase, 
resulting in a single GDP. The a and py subunits are then able to reassociate, become 
inactive, and return to the receptor (Neer, 1995). 
During the G protein cycle once the a and subunits have dissociated, each 
subunit is able produce its effect. The effect of the G proteins can be quite broad; 
influencing adenylate cyclase, kinases, phospolipases, and ion-channel exchanges (Forse, 
2000). It is the effect of the GPCR that can result in the diminished pain sensation caused 
by the opioid system (Shaqura et al., 2004). 
Pain 
Advances in the study of the opioid system have resulted in dramatic 
improvements of our understanding of pain mechanisms and methods of pain treatment. 
Pain can be classified into two groups, either acute pain or chronic pain. Acute pain is 
associated with tissue damage or injury that results from trauma or surgery. This form of 
pain is essential as part of a survival instinct to protect from further damage and to allow 
for recovery. However, chronic pain occurs as the result of disease, such as autoimmune 
mediated diseases. Some of the most common examples of diseases that can cause 
chronic pain are rheumatoid arthritis, systemic lupus erythematosus (SLE), and Graves' 
disease (Druckman, 2001). 
Treatment of chronic pain diseases differs from that of acute pain in that many of 
the mechanisms behind the disease and its continuation are unknown. Furthermore, 
many of the mechanisms and processes that occur as a result of acute pain have been 
established, such as the increased activity of particular endogenous opioid peptides 
(Millan et al., 1986). Due to the uncertainty surrounding chronic pain conditions, 
researchers are attempting to elucidate a greater understanding of the pain associated with 
these diseases. The use of inflammatory agents, including Complete Freund's Adjuvant, 
carrageenan, and formalin, are employed to simulate the chronic pain state in laboratory 
animals. 
Complete Freund's Adjuvant (CFA) is commonly used as the model for 
simulating chronic pain in male and female rats. Rats treated with CFA experience 
symptoms including inflammation, joint deterioration, and hyperalgesia, creating a 
diseased state comparable to Rheumatoid arthritis in humans (Colpaert, 1987). The 
inflammation and hyperalgesia produced by CFA results from alterations in several 
neuropeptide systems (Cox, 2004). Opioid systems are among those affected by 
administration of CFA, causing changes in the receptors, peptides, and mRNAs involved 
in producing opioid nociception (Millan, 1986). 
The polyarthritic state produced in the weeks following CFA administration 
results in significant effects on functions of the opioid systems. Increased levels of 
prodynorphin and proenkeplain are observed in the spinal and supraspinal neurons, which 
correspond to increased levels of the mRNAs encoding prodynorphin and proenkephalin 
(Hollt et al., 1987; Iadarola et al., 1988;). Chronic inflammatory conditions have also 
resulted in reductions in [~et~]-enkephalin-like peptides and levels of proenkephalin A 
mRNA in the dorsal root ganglia of arthritic rats (Pohl et al., 1997). 
Gonadal Hormones 
Whether the pain results from natural or experimental methods of pain, there are 
several factors that influence every aspect from sensation to analgesia. The presence of 
sex differences between male and female subjects is among these factors. Gonadal 
hormones in male and female animals are responsible for both organizational and 
activational effects. Organizational effects of steroid hormones occur in the late prenatal 
and early postnatal development of rats (Cicero et al., 2002). These effects include 
producing sexually appropriate physiology and behavior and making the brain sensitive 
to the activational effects of sex hormones during puberty. The activational effects do 
not appear until adulthood, when they are responsible for maintaining typical male and 
female sexual and other behaviors (Cicero et al., 2002). 
Many investigations attempting to determine the influence of the gonadal 
hormones on the body have been conducted with varying results. Gonadectomy and 
administration of estrogens or androgens are commonly used to study sex differences in 
laboratory animals. Krzanowska et al. (2002) and Cicero et al. (2002) successfully 
eliminated sex differences in morphine antinociception through the neonatal castration of 
male rats and by the administration of androgens to neonatal female rats. However, adult 
gonadectomy in both male and female rats did affect morphine analgesia, indicating that 
the organizational effects of sex hormones may be responsible for sex differences. 
Researchers examining the activational effects of gonadal hormones have discovered less 
consistent results in both males and females, showing increases, decreases, and no change 
in opioid analgesia after adult gonadectomy (Terner et al., 2002). 
Androgens, the primary gonadal hormones present in males, are produced 
primarily in the testes and to a lesser degree in the adrenal cortex (Aloisi, 2003). The 
primary androgens are testosterone and dihydrotestosterone. Although, generally 
considered male sex hormones, androgens are present in much lower levels in females. 
Female androgens are secreted from the ovaries and adrenal cortex in small amounts. 
This is also true for presence of the female gonadal hormones found in low 
concentrations in males (Craft et al., 2004). Aside from the role of testosterone in the 
production of male characteristics, it appears that testosterone provides some anti- 
inflammatory function. Lower levels of gonadal and adrenal androgens have been 
observed in male and female patients with rheumatoid arthritis when compared to control 
subjects (Navarro et a1.,1998; Cutolo et al., 2000). This anti-inflammatory effect of 
androgens has also been noted as a common factor in other chronic inflammatory 
diseases, like, fibromyalgia, systemic lupus erythematosus (SLE), and Graves' disease 
(Aloisi, 2003). 
There are two groups of hormones that comprise the female gonadal hormones, 
estrogens and progestins. The estrogens (estradiol, estriol, and estrone) and progestins 
(progesterone) are both produced primarily by the ovaries (Simpson, 2003). Unlike the 
androgens, estrogens are often linked to increased pain sensitivity in females. Korzun et 
al. (2000) observed increased pain, perceived stress, and depression associated with 
fibromyalgia during the luteal phase of the menstrual cycle of patients corresponding to 
high levels of estrogen and progesterone. Estrogens are also responsible for various non- 
reproductive effects, including bone formation, cardiovascular function, metabolic rate, 
water and salt balance, and hemostasis (Amandusson et al., 1999). 
Female hormone levels fluctuate at a much greater degree in females than males, 
due to processes such as the menstrual cycle, pregnancy, and menopause. Compared to 
males, the female reproductive system undergoes a much greater dynamic of change as 
the female progresses through life. Rat ovarian cycles consist of an estrus, or ovulation 
phase, lasting about 12 hours; then metestrus, or luteal phase, lasting for one day; then 
diestrus, or follicular phase, lasting 1-2 days; followed by proestrus, lasting about 12 
hours (Mahesh, 1985). Compared to males, cycling females demonstrate the greatest sex 
differences when in the estrus phase, indicated by low estradiol and progesterone levels 
(Craft et al., 2004). 
Pregnancy and menopause represent the extremes of the female hormonal 
spectrum. Pregnant females experience increased levels of progesterone and estrogen. 
Conversely, during menopause, females experience a dramatic decrease in the ovarian 
production of estrogens (Aloisi, 2003), which makes the aromatization of testosterone to 
estradiol the primary source of estrogens (Craft et al., 2004). After menopause, females 
rely on the extragonadal aromatization of androgens, like testosterone, androstenedione, 
dehydroepiandrosteone (DHEA), and DHEA sulphate (DHEAS) for the production of 
estrogens (Zhao et al., 2005). 
Correlations between gonadal hormone levels and pain suggest that both 
androgens and estrogens have important influences in pain modulation. In humans, this 
is seen in the significantly higher prevalence of autoimmune disease in human females 
than males (Druckmann, 2001). Also, injection of estradiol into male rats resulted in 
higher levels of formalin-induced licking than in control rats (Aloisi and Ceccarelli, 
2000), suggesting a pronociceptive effect of estrogen. Given the dramatic sex differences 
seen in prevalence of chronic pain diseases it seems likely that the ability of the gonadal 
hormones results from their impact on the opioid system. 
Rationale for Study and Hypotheses 
The majority of research on the endogenous opioid system has examined various 
pain assays and the efficacy of different opioid agonists. However, minimal attention has 
been focused at the effects of the gonadal hormones and their impact on the opioid 
peptide system. Sex differences in response to pain have been observed in both human 
and animal models (Przewlocki R. and Przewlocki B., 2001). Most studies have 
concluded that opioid analgesia is greater in males than females and also that females 
exhibit a greater nociceptive and hyperalgesic response to inflammatory agents and 
nociceptive stimuli (Wiesenfeld-Hallin, 2005). Many studies have found that these sex 
differences have been eliminated through the manipulation of gonadal steroids through 
castration in males and testosterone administration in females (Cicero et al., 2002; 
Krzanowska et al., 2002). 
The present study was designed to determine any effects of the gonadal hormones 
on the opioid receptor protein levels of CFA on treated male and female Lewis rats. 
Following a paw pressure pain assay, the midbrain and spinal cord tissues were collected 
for comparison of MOR, DOR, and KOR protein levels. Receptor protein levels should 
provide an estimate of the receptor density, which should be decreased in animals 
experiencing pain. It was hypothesized that male rats would feel less pain than female 
rats regardless of the presence of gonadal hormones and gonadectomy, which would 
result in a decreased pain threshold in male arthritic and nonarthritic rats. 
Materials and Methods 
Subjects 
Hormonally intact male and female Lewis rats approximately 60 days of age were 
obtained from Charles Rivers Laboratories (Raleigh, NC). Castrated (CAS) and 
ovariectomized (OVX) rats were also obtained from Charles Rivers Laboratories 
(Raleigh, NC), with the surgeries being performed when the rats were approximately 50 
days of age. All rats were allowed to acclimate to the vivarium until approximately 70 
days of age, at which time the experiment commenced. Rats were individually housed, 
had free access to food and water, and were maintained on 12112h lightldark cycle. 
CFA Administration 
On Day 1 animals were injected intradermally in the base of the tail with 0.1 ml of 5.0 
mglml Complete Freund's Adjuvant (CFA) (heat-killed Mycobacterium; Difco 
Laboratories, Detroit, MI) or 0.1 ml of vehicle (VEH) (mineral oil). 
Paw Thickness and Nociceptive Sensitivity Testing. 
Paw thickness (mm) of the left and right hindpaws was determined with a digital caliper. 
Nociceptive sensitivity was assessed on Day 19 by determining thresholds in response to 
mechanical pressure applied to the hindpaws of the rats. Rats were lightly restrained in a 
towel and a mechanical stimulus was applied with an analgesy meter (Ugo Basile, 
Varese, Italy), a device with a dome-shaped plastic tip (diameter = 1 mm) that applies a 
linearly increasing pressure (g) to the dorsal surface of the hindpaw, with the tip applied 
to the region of the paw just proximal to the third digit. On three separate occasions prior 
to Day 12 each rat was habituated to the paw pressure procedure. Habituation involved 
wrapping the rat lightly in a towel and placing one hindpaw on the plinth under the dome- 
shaped plastic tip. Increasing pressure was then applied until a withdrawal response was 
initiated. This habituation procedure was repeated for the other hindpaw. On Day 19, 
paw pressure thresholds were determined for both the left and right hindpaws with the 
order of testing counterbalanced across animals. 
Estrous Cycle Phase Determination 
Estrous cycle phase determination was determined in female rats by vaginal lavage on 
Day 19. The stages were identified based upon the type of cells detected. Proestrus 
phase was signified by a majority of round, nucleated cells, and an absence of leukocytes. 
Estrous phase was signified by a majority of cornified cells, and an absence of 
leukocytes. Metestrus phase was signified by the presence of round nucleated cells, 
cornified cells, and leukocytes. Diestrus phase was signified by the presence of all three 
cell types seen in metestrus, however, the number of cells in this phase was greatly 
reduced. 
Tissue Collection 
Following nociceptive testing, the rats were killed by rapid decapitation 19 days after 
complete Freund's adjuvant inoculation. Midbrain and spinal cord tissues were removed 
and immediately fiozen at -80°C. 
Tissue Preparation 
For each assay, spinal cord and midbrain tissue were thawed and homogenized in 10 ml 
cold IP buffer with protease inhibitors, followed by centrifugation at 3,500 x g for 12 
minutes at 4OC. The supernatant was transferred into clean 27 x 11 5 mm plastic 
centrifuge tubes and centrifuged at 20,000rpm for 33 minutes at 4OC. The supernatant 
was discarded, and the pellet was resuspended in IPIdetergent buffer, using 350 p1 for 
spinal cord tissue and 425 pL for midbrain tissue. To solubilize the pellets, they were left 
on ice and vortexed vigorously every 5 minutes for 1 hour. Tissues were then centrifuged 
at 12,000 rpm for 1 5minutes at 4OC. The supernatant was pipetted into 17 x 100 mm 
plastic culture tubes. Protein assays were conducted with the Bio-Rad Detergent 
Compatible assay kit. Protein samples were aliquotted and stored at -80°C. 
Western Immunoassays 
Electrophoresis was performed with a standard Laemrnli method. Samples were diluted 
1 : 1 with 2X sample buffer and loaded into a 1.5 mrn 8% SDS-PAGE gel. Protein (8 pg) 
was loaded into each gel for each of the receptors, MOR, DOR, and KOR. Following 
protein separation, transfer onto Immobilon-P PVD membrane (Millipore, Bedford, MA) 
was performed by the tank method. Blots were reversibly stained with Ponceau solution 
(Sigma Chemical Co.) blocked at least one hour in casein blocker in TBS (Pierce, 
Rockford, IL). The blots were incubated in the appropriate opioid receptor antibody 
concentrations overnight at room temperature (KOR, 1 :2000 in casein, DOR, 1: 10,000 in 
casein, MOR, 1 : 125 in casein). After washing three times in Tris-buffered saline plus 
0.5% Tween 20 (TBST) for 5 minutes, the blots were incubated in horseradish 
peroxidase-conjugated goat anti-rabbit IgG antiserum (Sigma Chemical Co.) at 1 :50,000 
dilution in casein for one hour at room temperature. Blots were washed again three times 
in TBST and then incubated for 5 minutes in Supersignal CL-HRP chemiluminescence 
(Pierce, Rockford, IL). Blots were then exposed on XAR-2 film (Eastman Kodak, 
Rochester, NY). Bands were quantified with scanning densitometry, and comparisons of 
the optical density values were performed by unpaired t-tests. 
Antibodies 
Anti-MOR-antibody (anti-acetyl-EAETAPLP-amide, C-terminal) was obtained from 
Research and Diagnostic Antibodies (Berkley, CA). Anti-DOR (anti-acetyl- 
CGRQEPGSLRRPRQA-amide, C-terminal, anti-KOR (anti-acetyl- 
SREKDRNLRRJTKL-amide, C-terminal) antibodies were obtained from Biosource 
International (Camarillo, CA). 
Data Analysis 
Following quantification of bands with scanning densitometry, the optical density ratios 
were calculated by dividing the respective GAPDH optical densities by the optical 
density of MOR, DOR, and KOR. The optical densities were reported as mean +. S.E.M. 
and tested for significance (p < 0.05) with the independent sample t-test in SPSS, Version 
12.0 for Windows. 
Results 
3.1. Paw pressure testing prior to tissue collection 
Male and female Lewis rats were tested to determine the effect of gonadectomy in 
vehicle and CFA treated rats using the paw pressure test. CFA-treated (arthritic - 
"Arth") animals, denoted by black bars, had significantly lower pain thresholds in both 
males and females regardless of the presence of gonadal hormones (Figure 1). A 
significant increase in the pain threshold of arthritic female rats was observed after 
ovariectomy. No significant differences were observed between intact and castrated non- 
arthritic or arthritic male rats. No significant difference was observed between non- 
arthritic intact and ovariectomized females. 
3.2. Effect of arthritis on female rats. 
Figure 2, Panels A, B, and C shows the optical density ratios of MOR, DOR, and 
KOR standardized to the GAPDH loading control. Non-arthritic rats are shown in white 
bars and arthritic rats in black bars. In Fig. 2.A no significant differences were observed 
in the midbrain ("Brain") of female Lewis rats when tested for MOR protein. Receptor 
protein levels in the spinal cord ("Cord") of non-arthritic gonadectomized ("GDX) 
female rats were significantly lower (p < 0.05) than in the arthritic gonadectomized 
females. No significant differences were observed in DOR protein levels in the midbrain 
or spinal cord tissues of non-arthritic and arthritic animals regardless of gonadectomy 
(Panel B). 
In Panel C, no significant differences were observed in the KOR protein of the 
midbrain tissue in intact and gonadectomized females. However, there were significant 
differences between the nonarthritic and arthritic spinal cord tissue of both intact and 
gonadectomized female rats. In the case of the intact rats, the development of arthritis 
resulted in a significant decrease in KOR protein in the cord. Gonadectomized rats 
conversely had lower levels of KOR protein in the non-arthritic rats compared to the 
intact non-arthritic rats. The induction of arthritis in the gonadectomized animals 
significantly increased KOR protein level in the spinal cord. 
3.3 Effect of arthritis on male rats. 
Figure 3, panels A, B, and C show the optical density ratios of MOR, DOR, and 
KOR proteins, respectively, standardized to the GAPDH loading control in male Lewis 
rats. In Panel A, the MOR protein level of the intact arthritic males is significantly higher 
than the intact non-arthritic midbrain tissue, but no difference is observed in the midbrain 
tissue of the castrated ("GDX") male rats. In the male spinal cord tissue, the MOR 
protein levels showed no significance differences between intact or castrated rats. 
There were no significant differences observed in the male DOR protein levels in 
the midbrain and spinal cord tissue, as seen in Panel B. (in arthritic or non-arthritic rats). 
The KOR protein level (Panel C) was not significantly different in the intact male 
midbrain tissue, although there is a trend for arthritis to decrease KOR protein levels in 
the midbrain. Gonadectomized arthritic males displayed higher KOR protein levels than 
the gonadectomized non-arthritic rats. Significantly higher levels of KOR protein were 
found in the spinal cord tissue of the intact non-arthritic male rats than the intact arthritic 
rats. Among the castrated arthritic and non-arthritic male spinal cord tissue no significant 
differences were observed. 
Sex Differences in MOR, DOR, and KOR 
Male and female data were directly compared in Fig 4, Panels A, B, and C to 
determine variations in MOR, DOR, and KOR protein levels. These figures display the 
male and female data comparing the midbrain ("MB") and cord tissues of arthritic and 
non-arthritic animals and of intact and gonadectomized animals. Fig 4.A shows the 
comparison of the MOR protein, in males and females, which shows significantly higher 
(p < 0.05) protein levels in the midbrain tissue of intact non-arthritic and arthritic male 
rats and also in nonartlwitic gonadectomized male rats versus female rats. The midbrain 
(MB) data also indicated a near significant difference between the MOR protein levels of 
male and female arthritic gonadectomized rats (p = 0.05). Male MOR protein levels were 
significantly higher in all spinal cord tissue versus that of female rats. 
No significant differences were observed between male and female midbrain 
DOR protein levels, as seen in Fig B. In the spinal cord, intact female rats had 
significantly higher DOR protein levels in both nonarthritic and arthritic rats compared to 
male rats. However, no significant differences were observed in the spinal cord DOR 
protein levels of arthritic and nonarthritic animals after gonadectomy, although the trend 
remains that the female DOR proteins are higher than male in cord. According to Fig 4., 
although intact male and female rats had similar KOR protein in MB when no arthritis 
was present, gonadectomy and arthritis significantly reduced KOR proteins in males, but 
had no effect on female MB KOR protein. Female KOR protein levels were significantly 
higher in all spinal cord tissue versus that of male rats. 
O V E H  C F A  
Male Female CAS 
Figure 1. The effect of gonadectomy and CFA treatment in male and female rats on paw 
pressure thresholds on day 19. Brackets indicate S.E.M. Asterisk (*) indicates a 
significant difference (Bonferroni's post hoc test) from same day VEH treatment group. 
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Figure 2. Effect of arthritis on MOR, DOR, and KOR protein levels in female rats are 
shown in Panels A, B, and C, respectively. The arthritic state was induced by an 
intradermal injection of Freund's adjuvant. The midbrain and spinal cord tissue were 
removed immediately after decapitation and frozen at -80°C. Bars represent the mean * 
S.E.M. of 3 female rats. * Indicates significant difference between non-arthritic and 
arthritic animals: P < 0.05 by an independent samples t-test. 
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Figure 3. Effect of arthritis on MOR, DOR, and KOR protein levels in male rats are 
shown in Panels A, B, and C, respectively. The arthritic state was induced by an 
intradermal injection of Freund's adjuvant. The midbrain and spinal cord tissue were 
removed immediately and stored at -80°C. Bars represent the mean =k S.E.M. of 3 male 
rats. * Indicates significant differences between non-arthritic and arthritic animals: P < 
0.05 by an independent samples t-test. 
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Figure 4. Sex Differences in MOR, DOR, and KOR. Effect of arthritis and 
gonadectomy on MOR, DOR, and KOR protein levels in male and female rats are shown 
in Panels A, B, and C, respectively. The arthritic state was induced by an intraderrnal 
injection of Freund's adjuvant. The midbrain and spinal cord tissue were removed 
immediately after decapitation and frozen at -80°C. Bars represent the mean * S.E.M. of 
3 male or female rats. * Indicates significant differences between non-arthritic and 
arthritic animals: P < 0.05 by an independent samples t-test. 
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Table 1. Optical Densities on MOR, DOR, and KOR. The data from scans of optical 
densities for the opioid receptor proteins standardized as a ratio to GAPDH are shown in 
Table 1. The data were the source for Figures 2-4, previously presented. Values in bold 
have significantly lower means than the opposite sex (independent samples t-test). 
A Significant difference vs. Intact Non-Arthritic of the same sex and location 
Significant difference vs. Intact Arthritic of the same sex location 
Significant difference vs Gonadectomized Arthritic of the same sex and location 
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Discussion 
Historically, most studies investigating sex differences on chronic pain have 
focused primarily on the use of opioid agonists and their relative efficacies based on the 
presence or absence of pain or gonadal hormones. The present study examined the role 
of gonadal hormones on opioid receptor protein levels in intact and gonadectomized, 
non-arthritic and CFA-induced arthritic Lewis rats. The presence of the gonadal 
hormones was demonstrated to have an important effect on the pain sensation in both 
male and female vehicle and CFA-treated rats. Within a single sex, the effect of 
gonadectomy also showed to be an important variable in the modulation of pain for males 
and females. Significant sex differences were observed in MOR and KOR protein levels, 
but not DOR protein. 
The effects of CFA-induced hyperalgesia resulted in significantly decreased pain 
thresholds in males and females, compared to vehicle treated animals in the paw pressure 
test (Fig 1). The spinal cord tissue of female Lewis rats may have a greater role in 
modulating pain sensations than midbrain tissues. CFA-treated female rats exhibited an 
increase in pain threshold after ovariectomy (Fig. I), which directly corresponds to a 
significant increase in KOR protein levels in the spinal cord of arthritic ovariectomized 
females (Fig 2, Panel C; Fig 4, Panel C). 
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High densities of KOR have been found in the lumbosacral region of the spinal 
cord of both rats and humans (Gouarderes et al., 1985). KOR protein levels of female 
intact non-arthritic cord tissue are significantly greater than that of the intact arthritic 
female; however, this difference is reversed by ovariectomy (Fig 2, Panel C). This trend 
toward increased pain threshold was also demonstratedd in MOR protein (Fig 2, Panel 
A), indicating a significant effect of the gonadal hormones in female pain modulation. 
The present findings also correlate with previous studies that observed an upregulation of 
dynorphin in the spinal cord of rats during pregnancy and parturition (Gintzler and 
Bohan, 1990; Medina et al., 1993). 
Androgens often function as natural anti-inflammatory hormones by suppressing 
both humoral and cellular immune responses (Stoffel et al., 2005). The role of the 
androgens in pain modulation has primarily been investigated by testing opioid analgesia 
in sham and gonadectomized animals. These studies have demonstrated mixed results 
after male gonadectomy, including increases, decreases, and no change. In the present 
study gonadectomy of males produced a stabilizing effect on opioid receptor protein in 
the midbrain and spinal cord of nonarthritic and arthritic rats. That is, MOR and KOR 
protein levels in the spinal cord tissue of nonarthritic male rats were significantly higher 
than in arthritic rats, however this difference was eliminated by the removal of .the 
gonadal hormones (Fig 3, Panels A and C). Gonadectomy produced similar results in the 
p receptor protein level in the male midbrain tissue as well (Figure 3, Panel A). 
However, the effects of gonadectomy in males was much less profound than in females. 
The data on the MOR protein in the midbrain along with MOR and KOR spinal cord 
receptor protein levels demonstrate the potential impact of the male gonadal hormones on 
opioid receptor proteins and suggests that gonadectomy may increase nociception. 
Similarly, Stoffel et al. (2005) reported decreased antinociception after gonadectomy in 
male rats treated with p and K opioids, but not 6 opioids. The small magnitude of change 
observed in opioid receptor proteins in males following gonadectomy may have little 
impact on pain perception. 
The presence of sex differences in opioid antinociception has been observed in 
both rodent (Kepler et al., 1989; Cicero et al., 1996, 1997; Kest et al., 1999) and non- 
human primate models (Negus and Mello, 1999). In the present study, sex differences 
were observed in both the p and K opioid receptor protein levels. The spinal cord tissue 
of male rats, regardless of the presence of gonads or arthritis displayed significantly 
greater levels of MOR protein levels than females (Fig. 4, Panel A). Male MOR protein 
levels were significantly greater in all tested midbrain tissue, except for the near 
significant difference (p = 0.05) seen in arthritic gonadectomized male (Fig. 4, Panel A). 
These results are consistent with previous studies that suggest greater opioid 
antinociception from p agonists in male rats. 
Despite these findings, KOR protein levels appear to have a significantly greater 
influence on pain sensation in female rats. Female KOR protein levels are significantly 
greater than males in all spinal cord tissue. KOR protein levels in female midbrain tissue 
were also significantly higher in the non-arthritic ovariectomized and arthritic intact 
female rats (Fig. 4, Panel C). According to previous studies, gonadectomized females 
displayed decreased opioid antinociception compared to intact females (Cicero et al., 
1996; Craft et al., 1996; Kest et al., 1999), which may have resulted from using y- 
selective agonists, such as morphine, fentanyl, and hydromorphone. The present study 
indicates the possibility of greater opioid analgesia in females with K-selective agonists. 
It is also important to mention that rodent strain may also function in modulating 
sensitivity to opioid-induced antinociception and determining the magnitude of sex 
differences. In previous studies, F344 and Lewis strains demonstrated greater sex 
differences than the Sprague-Dawley strain in potency and effectiveness of p-opioid 
agonists (Bartok and Craft, 1997; Barrett et al., 2001; Cook et al., 2000). The 
significantly greater KOR protein levels seen in the Lewis rats used in the present study, 
may correlate to the slightly more sensitive effects of U50,488, a kappa agonist, on 
female Lewis rats compared to male Lewis rats observed in a previous study (Barrett et 
al., 2001). 
The overall findings of the present study provide strong evidence for the 
importance of the gonadal hormones in the modulation of pain sensation in arthritic and 
nonarthritic Lewis rats, especially in the female rat. The removal of gonadal hormones 
appears to have opposite effects in males and females; causing decreased pain in females 
and increased pain in males. Under these conditions, pain sensation in males or females 
does not appear to be modulated by delta opioid receptor proteins. The presence of 
significantly greater MOR protein levels in male rats is in agreement with previous 
studies. However, a major implication of the present study is the greater levels of KOR 
protein in female rats, possibly indicating that usage of more K-selective opioid agonists, 
like U50,488, butorphanol and pentazocine, may demonstrate greater efficacy in 
providing pain relief to females. The administration of K-selective opioid agonists may 
also eliminate many of the negative effects of p-opioid agonists that women experience, 
including nausea, emesis, and constipation. 
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